ConductScience.org, home

Paper23328666

The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation.

Miekus K and 5 others. Cell Death Dis, 2013. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation. Papers, record 23328666. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23328666

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The decreased metastatic potential of rhabdomyosarcoma cells obtained through MET receptor downregulation and the induction of differentiation.
PubMed
Journal
Cell Death Dis
PubMed
Year
2013
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
0.89
iCite
Revised in PubMed
2021-10-21
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Miekus KK
2Lukasiewicz EE
3Jarocha DD
4Sekula MM
5Drabik GG
6Majka MM

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Proto-Oncogene Proteins c-metMajor topic
Animals
Bone Marrow Neoplasms
Cell Differentiation
Cell Line, Tumor
Cell Movement
Chemokine CXCL12
Down-Regulation
Hepatocyte Growth Factor
Humans
Mice
Mice, Inbred NOD
Mice, SCID
Mitogen-Activated Protein Kinase Kinases
MyoD Protein
Phosphorylation
Proto-Oncogene Proteins c-akt
RNA Interference
RNA, Small Interfering
Receptors, CXCR4
Rhabdomyosarcoma
Soft Tissue Neoplasms
Transplantation, Heterologous

Source PubMed

Download CSV of topics

References54

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119318576The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.Cancer Res2009https://conductscience.org/library/papers/19318576PubMed
222027690Breast cancer-derived bone metastasis can be effectively reduced through specific c-MET inhibitor tivantinib (ARQ 197) and shRNA c-MET knockdown.Mol Cancer Ther2012https://conductscience.org/library/papers/22027690PubMed
312239174CXCR4-SDF-1 signaling is active in rhabdomyosarcoma cells and regulates locomotion, chemotaxis, and adhesion.Blood2002https://conductscience.org/library/papers/12239174PubMed
418451162Frzb, a secreted Wnt antagonist, decreases growth and invasiveness of fibrosarcoma cells associated with inhibition of Met signaling.Cancer Res2008https://conductscience.org/library/papers/18451162PubMed
510498887Rhabdomyosarcoma--working out the pathways.Oncogene1999https://conductscience.org/library/papers/10498887PubMed
612684423c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.Clin Cancer Res2003https://conductscience.org/library/papers/12684423PubMed
715705897Silencing of CXCR4 blocks breast cancer metastasis.Cancer Res2005https://conductscience.org/library/papers/15705897PubMed
88187070Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.Cancer Res1994https://conductscience.org/library/papers/8187070PubMed
921551255Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis.Clin Cancer Res2011https://conductscience.org/library/papers/21551255PubMed
1020068066Regulation of expression of stromal-derived factor-1 receptors: CXCR4 and CXCR7 in human rhabdomyosarcomas.Mol Cancer Res2010https://conductscience.org/library/papers/20068066PubMed
1118175071The Met tyrosine kinase receptor in development and cancer.Cancer Metastasis Rev2008https://conductscience.org/library/papers/18175071PubMed
1217981628The biological role of HGF-MET axis in tumor growth and development of metastasis.Front Biosci2008https://conductscience.org/library/papers/17981628PubMed
133689591Myoglobin, desmin and vimentin in ultrastructurally proven rhabdomyomas and rhabdomyosarcomas. An immunohistochemical study utilizing a series of monoclonal and polyclonal antibodies.Appl Pathol1987https://conductscience.org/library/papers/3689591PubMed
1421926191Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth.Mol Cancer Ther2011https://conductscience.org/library/papers/21926191PubMed
1515735036Functional expression and mutations of c-Met and its therapeutic inhibition with SU11274 and small interfering RNA in non-small cell lung cancer.Cancer Res2005https://conductscience.org/library/papers/15735036PubMed
168789435In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma.Hum Mol Genet1996https://conductscience.org/library/papers/8789435PubMed
172558065Expression of desmin and myoglobin in rhabdomyosarcomas and in developing skeletal muscle.Histopathology1989https://conductscience.org/library/papers/2558065PubMed
187665696Desmin expression in rhabdomyosarcoma: influence of the desmin clone and immunohistochemical method.J Clin Pathol1995https://conductscience.org/library/papers/7665696PubMed
1917235634Detection of cancer cells disseminated in bone marrow using real-time quantitative RT-PCR of CEA, CK19, and CK20 mRNA in patients with gastric cancer.Gastric Cancer2006https://conductscience.org/library/papers/17235634PubMed
2015064724The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants.Oncogene2004https://conductscience.org/library/papers/15064724PubMed

See all 54 referencesDownload CSV of references

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
41507126The investigational anti-B7-H3 antibody-drug conjugate vobramitamab duocarmazine exerts anti-tumor activity in vitro and in vivo in pediatric sarcoma preclinical models.Cell Death Dis2026https://conductscience.org/library/papers/41507126PubMed
40508013Molecular Targets in Alveolar Rhabdomyosarcoma: A Narrative Review of Progress and Pitfalls.Int J Mol Sci2025https://conductscience.org/library/papers/40508013PubMed
39913888Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers.JCO Precis Oncol2025https://conductscience.org/library/papers/39913888PubMed
38474036Transforming Growth Factor Beta and Alveolar Rhabdomyosarcoma: A Challenge of Tumor Differentiation and Chemotherapy Response.Int J Mol Sci2024https://conductscience.org/library/papers/38474036PubMed
38076999Fusion-negative rhabdomyosarcoma orthotopic tongue xenografts for study of invasion, intravasation and metastasis in live animals.bioRxiv2023https://conductscience.org/library/papers/38076999PubMed
36034555The hepatocyte growth factor/mesenchymal epithelial transition factor axis in high-risk pediatric solid tumors and the anti-tumor activity of targeted therapeutic agents.Front Pediatr2022https://conductscience.org/library/papers/36034555PubMed
35574376MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression.Front Oncol2022https://conductscience.org/library/papers/35574376PubMed
35158790NanoString Digital Molecular Profiling of Protein and microRNA in Rhabdomyosarcoma.Cancers (Basel)2022https://conductscience.org/library/papers/35158790PubMed
34440639Progression and Differentiation of Alveolar Rhabdomyosarcoma Is Regulated by PAX7 Transcription Factor-Significance of Tumor Subclones.Cells2021https://conductscience.org/library/papers/34440639PubMed
32664538SNAIL Promotes Metastatic Behavior of Rhabdomyosarcoma by Increasing EZRIN and AKT Expression and Regulating MicroRNA Networks.Cancers (Basel)2020https://conductscience.org/library/papers/32664538PubMed
31949799c-MET expression potentially contributes to the poor prognosis of rhabdomyosarcoma.Int J Clin Exp Pathol2018https://conductscience.org/library/papers/31949799PubMed
30909397C-Met as a Key Factor Responsible for Sustaining Undifferentiated Phenotype and Therapy Resistance in Renal Carcinomas.Cells2019https://conductscience.org/library/papers/30909397PubMed
30617281Rhabdomyosarcoma.Nat Rev Dis Primers2019https://conductscience.org/library/papers/30617281PubMed
30373318Therapeutic Approaches Targeting PAX3-FOXO1 and Its Regulatory and Transcriptional Pathways in Rhabdomyosarcoma.Molecules2018https://conductscience.org/library/papers/30373318PubMed
29445192SPRY2 is a novel MET interactor that regulates metastatic potential and differentiation in rhabdomyosarcoma.Cell Death Dis2018https://conductscience.org/library/papers/29445192PubMed
27851822Tumor-Activated Mesenchymal Stromal Cells Promote Osteosarcoma Stemness and Migratory Potential via IL-6 Secretion.PLoS One2016https://conductscience.org/library/papers/27851822PubMed
27324022Identification of clinically achievable combination therapies in childhood rhabdomyosarcoma.Cancer Chemother Pharmacol2016https://conductscience.org/library/papers/27324022PubMed
26900544Microfabricated Systems and Assays for Studying the Cytoskeletal Organization, Micromechanics, and Motility Patterns of Cancerous Cells.Adv Mater Interfaces2014https://conductscience.org/library/papers/26900544PubMed
26384300Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.Oncotarget2015https://conductscience.org/library/papers/26384300PubMed
26162688Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors.Mol Cancer Ther2015https://conductscience.org/library/papers/26162688PubMed

See all 24 cited byDownload CSV of cited by

Genes21

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
CXCL126387PubTator's text mininghttps://conductscience.org/library/genes/6387NCBI Gene
CXCR47852PubTator's text mininghttps://conductscience.org/library/genes/7852NCBI Gene
DES1674PubTator's text mininghttps://conductscience.org/library/genes/1674NCBI Gene
ETS12113PubTator's text mininghttps://conductscience.org/library/genes/2113NCBI Gene
FSD179187PubTator's text mininghttps://conductscience.org/library/genes/79187NCBI Gene
GAPDH2597PubTator's text mininghttps://conductscience.org/library/genes/2597NCBI Gene
HGF3082PubTator's text mininghttps://conductscience.org/library/genes/3082NCBI Gene
MET4233PubTator's text mininghttps://conductscience.org/library/genes/4233NCBI Gene
MIR206406989PubTator's text mininghttps://conductscience.org/library/genes/406989NCBI Gene
MSTN2660PubTator's text mininghttps://conductscience.org/library/genes/2660NCBI Gene
MYOD14654PubTator's text mininghttps://conductscience.org/library/genes/4654NCBI Gene
MYOG4656PubTator's text mininghttps://conductscience.org/library/genes/4656NCBI Gene
NFKB14790PubTator's text mininghttps://conductscience.org/library/genes/4790NCBI Gene
PAX35077PubTator's text mininghttps://conductscience.org/library/genes/5077NCBI Gene
PAX75081PubTator's text mininghttps://conductscience.org/library/genes/5081NCBI Gene
RHD6007PubTator's text mininghttps://conductscience.org/library/genes/6007NCBI Gene
SLTM79811PubTator's text mininghttps://conductscience.org/library/genes/79811NCBI Gene
SRC6714PubTator's text mininghttps://conductscience.org/library/genes/6714NCBI Gene
TXK7294PubTator's text mininghttps://conductscience.org/library/genes/7294NCBI Gene

See all 21 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23328666

GET https://conductscience.org/api/papers/v1/23328666/references?page=2